Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    INVO Bioscience Inc.

    NASDAQ: INVO · Real-Time Price · USD
    0.83
    -0.02 (-2.35%)
    At close: Oct 21, 2024, 10:00 PM

    INVO Bioscience Statistics

    Share Statistics

    INVO Bioscience has 3.91M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 3.91M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0.84%

    Shares Floating

    n/a
    		 3.88M

    Failed to Deliver (FTD) Shares

    n/a
    		 214

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.26 and the forward PE ratio is null. INVO Bioscience's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.26

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.7

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.37

    P/FCF Ratio

    n/a
    		 -0.41

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    INVO Bioscience has an Enterprise Value (EV) of 10.57M.

    EV / Sales

    n/a
    		 3.5

    EV / EBITDA

    n/a
    		 -1.54

    EV / EBIT

    n/a
    		 -2.22

    EV / FCF

    n/a
    		 -2.03

    Financial Position

    The company has a current ratio of 0.15, with a Debt / Equity ratio of 3.1.

    Current Ratio

    n/a
    		 0.15

    Quick Ratio

    n/a
    		 0.12

    Debt / Equity

    n/a
    		 3.1

    Debt / EBITDA

    n/a
    		 -1.26

    Debt / FCF

    n/a
    		 -1.67

    Interest Coverage

    n/a
    		 -7.31

    Financial Efficiency

    Return on Equity is -899.91% and Return on Invested Capital is -185.7%.

    Return on Equity

    n/a
    		 -899.91%

    Return on Assets

    n/a
    		 -38.47%

    Return on Invested Capital

    n/a
    		 -185.7%

    Revenue Per Employee

    n/a
    		 $120,823

    Profits Per Employee

    n/a
    		 $-321,384.48

    Employee Count

    n/a
    		 25

    Asset Turnover

    n/a
    		 0.14

    Inventory Turnover

    n/a
    		 7.31

    Taxes

    Income Tax

    n/a
    		 27.79K

    Effective Tax Rate

    n/a
    		 -0.35%

    Stock Price Statistics

    The stock price has increased by 9.2% in the last 52 weeks. The beta is 1.44, so INVO Bioscience's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.44

    52-Week Price Change

    n/a
    		 9.2%

    50-Day Moving Average

    n/a
    		 0.78

    200-Day Moving Average

    n/a
    		 0.9

    Relative Strength Index (RSI)

    n/a
    		 48.55

    Average Volume (20 Days)

    n/a
    		 1,149,370

    Income Statement

    In the last 12 months, INVO Bioscience had revenue of 3.02M and earned -8.03M in profits. Earnings per share was -5.13.

    Revenue

    n/a
    		 3.02M

    Gross Profit

    n/a
    		 1.09M

    Operating Income

    n/a
    		 -6.77M

    Net Income

    n/a
    		 -8.03M

    EBITDA

    n/a
    		 -6.88M

    EBIT

    n/a
    		 -7.08M

    Earnings Per Share (EPS)

    n/a
    		 -5.13
    Full Income Statement

    Balance Sheet

    The company has 232.42K in cash and 8.68M in debt, giving a net cash position of -8.45M.

    Cash & Cash Equivalents

    n/a
    		 232.42K

    Total Debt

    n/a
    		 8.68M

    Net Cash

    n/a
    		 -8.45M

    Retained Earnings

    n/a
    		 -57.82M

    Total Assets

    n/a
    		 18.03M

    Working Capital

    n/a
    		 -5.59M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4.76M and capital expenditures -444.72K, giving a free cash flow of -5.2M.

    Operating Cash Flow

    n/a
    		 -4.76M

    Capital Expenditures

    n/a
    		 -444.72K

    Free Cash Flow

    n/a
    		 -5.2M

    FCF Per Share

    n/a
    		 -3.32
    Full Cash Flow Statement

    Margins

    Gross margin is 35.96%, with operating and profit margins of -224.04% and -266%.

    Gross Margin

    n/a
    		 35.96%

    Operating Margin

    n/a
    		 -224.04%

    Pretax Margin

    n/a
    		 -265.08%

    Profit Margin

    n/a
    		 -266%

    EBITDA Margin

    n/a
    		 -227.77%

    EBIT Margin

    n/a
    		 -224.04%

    FCF Margin

    n/a
    		 -172.15%

    Dividends & Yields

    INVO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -380.06%

    FCF Yield

    n/a
    		 -245.96%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for INVO.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 8.11

    Graham Upside

    n/a
    		 877.11%

    Stock Splits

    The last stock split was on Jul 28, 2023. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Jul 28, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -5.84

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist